The Spot Check Episode 27:

Beyond the Package Insert: Prescriber Psychology, Biologic Risk & Real-World Counseling

Featuring E. James Song, MD | Release Date: November 19, 2026


In residency, E. James Song, MD, got one piece of advice from an attending: whatever kind of practice he built, he should take seriously what it costs a patient when their disease goes undertreated.

In this episode of The Spot Check, host Jamie Restivo, MPAS, PA-C, asks Dr Song about the moment that advice gets tested. You know what a medication could do for a patient, you’ve read the safety data, and you still hesitate before signing the prescription. Their conversation covers:

  • Reading the trial behind a warning, including how much cardiovascular data on JAK inhibitors from older adults with rheumatoid arthritis can tell you about a younger patient with atopic dermatitis

  • Why one rare adverse event can weigh more heavily on a prescriber than the everyday burden of uncontrolled disease

  • How Dr Song explains the link between IL-17 inhibition and oral candidiasis with bimekizumab, and how he treats thrush if it occurs

  • The evidence behind the shifting approach on tuberculosis screening with IL-17 and IL-23 inhibitors

  • Talking about suicidal thoughts when the role of the drug and the burden of the disease are hard to separate

On that last point, Dr Song keeps his message to patients simple: if something changes in how they’re feeling, it matters to him, whatever the cause, and he wants to hear about it right away.

Related CME